Research progress on gene mutations and targeted therapy of type II endometrial carcinoma

Basic & Clinical Medicine ›› 2019, Vol. 39 ›› Issue (2): 277-280.

Research progress on gene mutations and targeted therapy of type II endometrial carcinoma

Hai-Fang WUXiang-Yu MENG²,Heng-Yi Xu², ²

Received:2017-11-23 Revised:2018-01-24 Online:2019-02-05 Published:2019-01-16

Abstract

Hai-Fang WU Xiang-Yu MENG Heng-Yi Xu. Research progress on gene mutations and targeted therapy of type II endometrial carcinoma[J]. Basic & Clinical Medicine, 2019, 39(2): 277-280.

[1]	LIU Cuiling, YU Shuna. Research progress in the role of NLRP3 inflammasome in hepatic ischemia-reperfusion injury [J]. Basic & Clinical Medicine, 2026, 46(7): 1004-1008.
[2]	LIU Pengpeng, SUN Zhao, QIU Wei, TANG Hui, ZHU Wenjia, WANG Wenhui, WANG Yingyi. Impact of local radiotherapy on tyrosine kinase inhibitor treatment in non-small cell lung cancer with oligo-residual disease [J]. Basic & Clinical Medicine, 2026, 46(4): 491-497.
[3]	LI Zhitao, BU Xuefeng, ZHANG Yongjun, MENG Nana, XIA Leizhou. Farnesoid X receptor suppresses pancreatic cancer cell proliferation through negative regulation of matrix metalloproteinase 7 [J]. Basic & Clinical Medicine, 2026, 46(2): 250-255.
[4]	KANG Lei, ZHU Junlan. Molecular mechanisms of selenium binding protein 1 expression regulation in cancer cells [J]. Basic & Clinical Medicine, 2025, 45(9): 1224-1228.
[5]	CHEN Lei,REN Weihao,WANG Lide. Knockdown of translocase of inner mitochondrial membrane 8A enhances gefitinib sensitivity to lung cancer cell line PC-9 [J]. Basic & Clinical Medicine, 2025, 45(8): 1073-1077.
[6]	LIU Fengshuo, GUAN Mei. Treatment of antibody-drug conjugates in elderly patients [J]. Basic & Clinical Medicine, 2025, 45(10): 1270-1276.
[7]	GAO Yidan, JIANG Xuehan, ZHANG Hong, YANG Peiran. Development of novel therapies targeting at dysregulated signaling pathways in pulmonary arterial hypertension [J]. Basic & Clinical Medicine, 2024, 44(8): 1088-1093.
[8]	DUAN Ran, LI Qingyuan, FENG Tong. Metabolic reprogramming in idiopathic pulmonary fibrosis [J]. Basic & Clinical Medicine, 2024, 44(6): 882-886.
[9]	. Drug therapy for intracranial germ cell tumor [J]. Basic & Clinical Medicine, 2024, 44(10): 1350-1356.
[10]	. Advances in pharmacotherapy for angiosarcoma [J]. Basic & Clinical Medicine, 2024, 44(10): 1363-1367.
[11]	. Targeted therapy and immunotherapy for malignant mesothelioma [J]. Basic & Clinical Medicine, 2024, 44(10): 1342-1349.
[12]	LIU Jingwen, SONG Haoxin, ZHU Lei. Construction and drug resistance evaluation of cell strains which stably express FIP1L1-PDGFRA protein and its mutants [J]. Basic & Clinical Medicine, 2024, 44(1): 63-68.
[13]	GONG Ziqi, WU Xiaowen, GUO Qian, GUO Jun, KONG Yan. Influence of PTEN mutation on pathological features and prognosis of patients with mucosal melanoma [J]. Basic & Clinical Medicine, 2023, 43(9): 1341-1345.
[14]	HE Dan, RUAN Zhong-bao. Extracellular vesicles in the pathogenesis of atrial fibrillation [J]. Basic & Clinical Medicine, 2022, 42(4): 671-674.
[15]	LYU Xue, LI Xue-wei, YANG Ting, ZHENG Jin-xiu, ZHU Zi-he, YANG Tao, XU Jun. Bioinformatic analysis of adenocarcinoma at esophagogastric junction and mutation sites screening of Involucrin gene [J]. Basic & Clinical Medicine, 2022, 42(2): 235-242.

Research progress on gene mutations and targeted therapy of type II endometrial carcinoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments